Gemcitabin Actavis 40mg/ml (25ml vial) Concentrate for solution for infusion Malta - English - Medicines Authority

gemcitabin actavis 40mg/ml (25ml vial) concentrate for solution for infusion

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - gemcitabine - concentrate for solution for infusion - gemcitabine 1 g - antineoplastic agents

Gemcitabin Actavis 40mg/ml (50ml vial) Concentrate for solution for infusion Malta - English - Medicines Authority

gemcitabin actavis 40mg/ml (50ml vial) concentrate for solution for infusion

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - gemcitabine - concentrate for solution for infusion - gemcitabine 2 g - antineoplastic agents

Valaciclovir Actavis Australia - English - Department of Health (Therapeutic Goods Administration)

valaciclovir actavis

actavis australia pty ltd - valaciclovir hydrochloride monohydrate; valaciclovir (as hydrochloride monohydrate); valaciclovir hydrochloride -

Topiramate Actavis 15 15 mg Capsule New Zealand - English - Medsafe (Medicines Safety Authority)

topiramate actavis 15 15 mg capsule

actavis new zealand limited - topiramate 15 mg - capsule - 15 mg - arrow - topiramate is indicated in adults and children 2 years and over:- as monotherapy in patients with newly diagnosed epilepsy - for conversion to monotherapy in patients with epilepsy - as add-on therapy in partial onset seizures, generalised tonic-clonic seizures or seizures associated with lennox-gastaut syndrome.

Topiramate Actavis 25 New Zealand - English - Medsafe (Medicines Safety Authority)

topiramate actavis 25

actavis new zealand limited - topiramate 25mg - capsule - 25 mg - active: topiramate 25mg excipient: aniseed ethanol gelatin magnesium stearate opadry white 85f18378 povidone purified water saccharin sodium sugar spheres tekprint black sw-9008 titanium dioxide - arrow - topiramate is indicated in adults and children 2 years and over: - as monotherapy in patients with newly diagnosed epilepsy - for conversion to monotherapy in patients with epilepsy - as add-on therapy in partial onset seizures, generalised tonic-clonic seizures or seizures associated with lennox-gastaut syndrome.